FNDC5 and metabolic disease: Moreover, based on preclinical studies, certain cytokines (FGF21, leptin, adiponectin, irisin) that can induce improvements in glucose and lipid metabolism and may emerge as novel targets of broader and more efficacious treatments and prevention of metabolic disease.